A three-snoRNA signature: SNORD15A, SNORD35B and SNORD60 as novel biomarker for renal cell carcinoma

Table 4 Correlation between snoRNA expression in US and clinicopathologic characteristics of RCC patients

Characteristics		Cases	SNORD15A	SNORD35B	SNORD60
Characteristics		Cases	P Value	P Value	P Value
Gender	Male	64	0.3018	0.3916	0.6384
Gender	Female	36	0.3018	0.3916	0.6384
Age	>=50	78	0.9819	0.6020	0.7450
Age	< 50	22	0.9819	0.6020	0.7450
T stage	T1	55	0.2128	0.3201	0.8505
	T2	8
	T3	29
	T4	4
	Not Available	4
Lymph node metastasis	N0	87	0.9372	0.9275	0.7408
	N1	10
	Not Available	3
Distant metastasis	M0	75	0.6641	0.8185	0.5133
	M1	22
	Not Available	3
TNM stage	I	54	0.0322*	0.5360	0.6950
	II	3
	III	18
	IV	23
	Not Available	2
Grade	G1G2	49	0.2208	0.2173	0.4575
	G3G4	29
	Not Available	22
Pathological type	ccRcc	93	0.5670	0.9598	0.6738
Pathological type	others	7	0.5670	0.9598	0.6738
Smoking	Yes	30	0.0436*	0.2735	0.0274*
Smoking	No	70	0.0436*	0.2735	0.0274*
Drinking	Yes	28	0.8115	0.8962	0.1924
Drinking	No	72	0.8115	0.8962	0.1924

ISSN: 1475-2867